K E Langley
- Immunology and Allergy top 1%
- Hematology top 2%
- Chronic Myeloid Leukemia Treatments 3
- Blood Coagulation and Thrombosis Mechanisms 3
- Platelet Disorders and Treatments 2
- Cancer Research top 2%
- Protease and Inhibitor Mechanisms 6
- Immunology top 5%
- Mast cells and histamine 6
- Oncology top 5%
- Peptidase Inhibition and Analysis 4
-
- Virus-based gene therapy research 2
-
- Erythrocyte Function and Pathophysiology 2
K E Langley
21 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 100
- Immunology and Allergy 394
- Hematology 574
- Cancer Research 748
- Immunology 747
- Oncology 732
Countries citing papers authored by K E Langley
This map shows the geographic impact of K E Langley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K E Langley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K E Langley more than expected).
Fields of papers citing papers by K E Langley
This network shows the impact of papers produced by K E Langley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K E Langley. The network helps show where K E Langley may publish in the future.
Co-authorship network
The 25 scholars most cited alongside K E Langley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 39 | |
| 2 | 1995 | 57 | |
| 3 | 1995 | 59 | |
| 4 | Melanoma-mediated dissolution of extracellular matrix: contribution of urokinase-dependent and metalloproteinase-dependent proteolytic pathways. | 1993 | 94 |
| 5 | 1993 | 57 | |
| 6 | 1993 | 18 | |
| 7 | 1993 | 98 | |
| 8 | 1993 | 120 | |
| 9 | Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. | 1992 | 375 |
| 10 | 1991 | 186 | |
| 11 | 1991 | 358 | |
| 12 | 1991 | 134 | |
| 13 | 1991 | 17 | |
| 14 | 1991 | 117 | |
| 15 | 1990 | 24 | |
| 16 | 1989 | 178 | |
| 17 | 1988 | 4 | |
| 18 | 1988 | 55 | |
| 19 | 1975 | 161 | |
| 20 | 1975 | 52 |
About K E Langley
K E Langley is a scholar working on Hematology, Immunology and Cancer Research, having authored 21 papers that have together received 2.3k indexed citations. Recurring topics across this work include Mast cells and histamine (6 papers), Protease and Inhibitor Mechanisms (6 papers), Peptidase Inhibition and Analysis (4 papers), Chronic Myeloid Leukemia Treatments (3 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers), Virus-based gene therapy research (2 papers), Platelet Disorders and Treatments (2 papers) and Erythrocyte Function and Pathophysiology (2 papers). The work is most often cited by research in Immunology and Allergy (394 citations), Hematology (574 citations) and Cancer Research (748 citations). K E Langley has collaborated with scholars based in United States, South Africa and France. Frequent co-authors include Yves A. DeClerck, K M Zsebo, Thomas C. Boone, Hiroyuki Shimada, Shirley M. Taylor, N Pérez, I K McNiece, Yves A. De Clerck, Irving Zabin and A.V. Fowler. Their work appears in journals such as Blood, Journal of Biological Chemistry, The Journal of Immunology, Biochemical Journal and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.